FreeTCL Archive Group Chairs: Research in “Crisis”ASCO Says NCTN Budgets Cut by 40 Percent, Warns of "Dangerous Disruption of Cancer Care" April 04, 2014Vol.40 No.14By Paul Goldberg
Drugs & TargetsFreeTCCL Archive European Commission Approves Subcutaneous Rituximab March 31, 2014Vol.37 No.03
FreeTCCL Archive Study: End-of-Life Chemotherapy Leads to More Deaths in Hospital March 31, 2014Vol.37 No.03
FreeTCCL Archive Study: Robotic-Assisted Surgery Offers Better Cancer Control March 31, 2014Vol.37 No.03
FreeTCCL Archive Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study March 31, 2014Vol.37 No.03
FreeTCCL Archive Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial March 31, 2014Vol.37 No.03
FreeTCCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 31, 2014Vol.37 No.03
FreeTCCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 31, 2014Vol.37 No.03
